CompanyGraphWhat stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $6.77B, above the global median of $1.15B
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
9.57TKRW6.77B · vs all stocks (USD)
Revenue (TTM)
1.51TKRW1.07B · vs all stocks (USD)
Profit Margin
33.90%vs Biotechnology peers
52-Week Change
-16.76%vs all stocks
Market Capitalization
9.57TKRW6.77B · vs all stocks (USD)
Enterprise Value
10.18TKRW7.21B · vs all stocks (USD)
Forward P/E
24.98xvs Biotechnology peers
Price to Sales (TTM)
6.34xvs Biotechnology peers
Enterprise to Revenue
6.74xvs Biotechnology peers
Profit Margin
33.90%vs Biotechnology peers
Operating Margin
19.95%vs Biotechnology peers
Revenue (TTM)
1.51TKRW1.07B · vs all stocks (USD)
Revenue per Share (TTM)
60.76KKRWUpdated Aug 19, 2026Gross Profit (TTM)
546.02BKRW386.60M · vs all stocks (USD)
EBITDA (TTM)
26.82BKRW18.99M · vs all stocks (USD)
Net Income (TTM)
511.88BKRW362.43M · vs all stocks (USD)
Operating Cash Flow (TTM)
-622.47BKRW-440.73M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
0.00KRWvs all stocks (USD)
Shares Outstanding
24.88MSharesUpdated Aug 19, 2026Float Shares
6.39MSharesUpdated Aug 19, 2026% Held by Insiders
74.28%vs all stocks
% Held by Institutions
12.35%vs all stocks
Total Cash (MRQ)
113.52BKRW80.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.57KKRWUpdated Aug 19, 2026Total Debt (MRQ)
743.20BKRW526.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1237xvs Biotechnology peers
Current Ratio (MRQ)
1.36xvs Biotechnology peers
52-Week Low
329.00KKRWUpdated Aug 19, 202652-Week High
773.00KKRWUpdated Aug 19, 202652-Week Change
-16.76%vs all stocks
50-Day MA
406.49KKRWUpdated Aug 19, 2026200-Day MA
526.78KKRWUpdated Aug 19, 2026Avg 10-Day Volume
50.17KSharesUpdated Aug 19, 2026Avg 30-Day Volume
52.43KSharesUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 362,430,775.304Operating Cash Flow (USD, TTM): -440,733,592.55
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $6.77B, above the global median of $1.15BNotable
Market cap (USD): 6,774,195,598.368Global Median: 1,146,734,693.424
Revenue is $1.07B, above the global median of $520.53MNotable
Revenue (USD): 1,069,239,353.223Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Cogent Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Xenon Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Glenmark Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Erasca, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lantheus Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ptc Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Biocon Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Getinge AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Liquidia Corporation
Tier 1ProductionApproval-Gated PipelineRule
H. Lundbeck A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow